This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Melnykovych, G. Articles by Gray, S. L. Search for Related Content PubMed PubMed Citation Articles by Melnykovych, G. Articles by Gray, S. L.

Corticosteroids and Phosphatidylcholine Biosynthesis in Microsomal Fractions from L5178Y Lymphoma¹

Research Service, United States Veterans Administration Hospital, Kansas City, Missouri 64128 [G. M., M. M. S., S. L. G.], and Department of Microbiology, University of Kansas Medical School, Kansas City, Kansas 66103 [G. M., E. R. M.]

Microsomal fractions from mouse lymphoma L5178Y and from rat thymocytes were used to follow incorporation of radiolabel from cytidine diphosphate-[methyl-¹⁴C]choline into microsomal lipids. Dexamethasone, at concentrations ranging from 2.8 x 10^-6 M to 2.8 x 10^-5 M, partially inhibited this transfer reaction. Microsomes prepared from freshly isolated thymocytes were more sensitive to the effects of dexamethasone showing inhibition at concentrations of steroid as low as 2.8 x 10^-8 M. The inhibitory effect did not depend on the amount of the available endogenous diglycerides and was not related to a possible stimulation of cytidine diphosphate choline transferase back reaction by the steroid.

The survey of a broad selection of different steroids revealed a lack of correlation between the known lymphocytolytic properties of steroids and their effects on cytidine diphosphate choline transferase. Dexamethasone was the only steroid of the glucocorticoid group that inhibited this reaction in microsomal fractions of L5178Y lymphoma. The structural requirement for the inhibitory effect was related to the absence of oxygen functions in positions 11 and 17 of the steroid and, possibly, to the presence of both C-20 and C-21 on the side chain.

¹ This investigation was supported in part by USPHS Research Grant CA-08315 from the National Cancer Institute.

² To whom requests for reprints should be sent, at: Research Service (151), Veterans Administration Hospital, 4801 Linwood Boulevard, Kansas City, Mo. 64128.

Received 10/28/75. Accepted 1/16/76.